Key Influencer in the Anti-Rabies Serum Market 2025: The Rise In The Prevalence Of Dog Bites Propelling The Growth Of The Anti-Rabies Serum Market Driver

What Is the Forecasted Market Size and Growth Rate for the Anti-Rabies Serum Market?
In recent times, the market size for anti-rabies serum has witnessed robust growth. An increase from $1.42 billion in 2024 to $1.5 billion in 2025 is projected, representing a compound annual growth rate (CAGR) of 5.7%. The powerful growth witnessed during the historic duration can be linked to several factors such as the growth in animal numbers, extensive implementation of vaccination programs, enhanced diagnostic methodologies, an increase in travel and migration, along with escalating public health initiatives, and the increasing frequency of wildlife encounters.

In the coming years, the anti-rabies serum market is predicted to witness significant expansion, reaching a valuation of $1.85 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 5.4%. Factors propelling growth during the forecast period include an increase in animal bite cases, augmented funding for rabies-related research, elevated cognizance of zoonotic diseases, improvements in handling and storage of serum, and greater endorsements for rabies control schemes. The prediction for the forecast period also involves trends like the development of novel serum formulations, enhancements in healthcare infrastructure, technological progress in the manufacture of serum, the creation of alternative delivery systems, and the invention of quick diagnostic kits.

What Factors Are Propelling the Expansion of the Anti-Rabies Serum Market?
The increasing occurrence of dog-bite incidents is anticipated to fuel the expansion of the anti-rabies serum market. Dog bites, which refer to harm inflicted upon a human by a digging or scratching dog, range from trivial to critical. These bites could result in infections, significant wounds, and possibly the transmission of diseases like rabies. Handling and reducing the risks associated with dog bites requires efficient deterrence and swift medical attention. The surge in dog bites owes to multiple factors, such as escalating urbanisation racking up interactions between dogs and humans, increasing numbers of unmuzzled or inadequately trained dogs, along with lack of sufficient knowledge about dog behaviour and bite prevention techniques. This upswing in dog bites is triggering a rise in the demand for anti-rabies serum because a prompt application of the serum is vital to prevent the inception of rabies in individuals exposed to potentially infected animals. For example, in 2023, as reported by the American Veterinary Medical Association, a non-profit organisation based in the US, the average cost of dog bite insurance claims amounted to $58,545. Insurers settled dog bite and other canine-related injury claims worth $1.12B in 2023. Dog bite claims marked an almost 10% increase in 2023. Therefore, the escalating occurrence of dog bites is propelling the growth of the anti-rabies serum market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp

Which Businesses Are at the Forefront of Anti-Rabies Serum Market Development?
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd ., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals

Which Businesses Are at the Forefront of Market Development?
Major players in the anti-rabies serum market are utilizing strategic alliances as a tool to bolster product innovation and broaden their market influence. 'Strategic alliances' refers to a course of action where businesses tap into each other's capabilities and assets in pursuit of shared advantages and triumphs. For example, Kedrion S.p.A, an American biopharmaceutical organization, allied with Kamada, a biopharmaceutical company from Israel, to distribute KEDRAB (Rabies Immune Globulin [Human]) in America, as of July 2023. This collaboration has played a key role in jointly developing and licensing the product within the U.S. market and increasing awareness about the disease. The concerted efforts of the partnership have been instrumental in safeguarding people subjected to bites from rabid animals, potentially preventing grave and life-threatening circumstances.

How Is the Anti-Rabies Serum Market Segmented?
The anti-rabies serum market covered in this report is segmented -

1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals

Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report

Where Is the Anti-Rabies Serum Market Growth Most Prominent?
North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Anti-Rabies Serum Global Market Report?

- Market Size Analysis: Analyze the anti-rabies serum Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the anti-rabies serum market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall anti-rabies serum market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the anti-rabies serum market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20468

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.